Browse by region

World Map Middle East Africa South Asia Asia/Pacific Europe South America North America

The Netherlands grants export license for mutant flu work

(Nature.com) The Dutch government has agreed to grant an export license to allow Ron Fouchier, a virologist at the Erasmus Medical University in Rotterdam, to publish his work on H5N1 avian influenza in Science. Fouchier’s paper is one of two reporting the creation of forms of the H5N1 virus capable of  Read More »

Flu Research Moratorium Should Continue, Fauci Says

(Science Now) Although the contention over whether to publish two controversial H5N1 avian influenza studies appears to be waning, researchers should continue to abide by a voluntary moratorium on certain types of studies involving the virus, a senior U.S. science official said today. There should be “an extension on the moratorium,”  Read More »

Senate Hearing on H5N1 papers exposes political divides

(Nature News Blog) Today in Washington D.C., US Senator Joseph Lieberman of Connecticut revealed that his grandmother was killed by influenza during the 1918 pandemic. This was one reason he has been so interested in a pair of yet-to-be-published papers on laboratory-created H5N1 avian influenza strains that could conceivably prove many  Read More »

Senate committee seeks answers in H5N1 study debate

(CIDRAP) Spurred by events surrounding two controversial H5N1 transmission studies, a US Senate committee today questioned federal officials whose agencies have a stake in dual-use research of concern (DURC) about the procedures they use to spot possible bioterror threats. Today’s Senate committee hearing marked the first time officials have testified before  Read More »

Scientific freedom and security

(The Economist) RON FOUCHIER (pictured), of the Erasmus Medical Centre in Rotterdam, is the lead author of a controversial paper which lays out how deadly H5N1 avian influenza, or bird flu, can be made deadlier still. He believes this information should be widely disseminated, so that biologists can work on drugs  Read More »